These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 33105694)
1. Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules. Mohan S; Elhassan Taha MM; Makeen HA; Alhazmi HA; Al Bratty M; Sultana S; Ahsan W; Najmi A; Khalid A Molecules; 2020 Oct; 25(21):. PubMed ID: 33105694 [TBL] [Abstract][Full Text] [Related]
2. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205 [TBL] [Abstract][Full Text] [Related]
3. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection. Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606 [TBL] [Abstract][Full Text] [Related]
4. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. McCarty MF; DiNicolantonio JJ Prog Cardiovasc Dis; 2020; 63(3):383-385. PubMed ID: 32061635 [No Abstract] [Full Text] [Related]
5. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules. Prasad A; Muthamilarasan M; Prasad M Plant Cell Rep; 2020 Sep; 39(9):1109-1114. PubMed ID: 32561979 [TBL] [Abstract][Full Text] [Related]
6. A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals. Chitalia VC; Munawar AH J Transl Med; 2020 Oct; 18(1):390. PubMed ID: 33059719 [TBL] [Abstract][Full Text] [Related]
7. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115 [TBL] [Abstract][Full Text] [Related]
8. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629 [TBL] [Abstract][Full Text] [Related]
9. Drug Discovery Strategies for SARS-CoV-2. Shyr ZA; Gorshkov K; Chen CZ; Zheng W J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and Computational Approach of Selected Phytocompounds from Rakib A; Paul A; Chy MNU; Sami SA; Baral SK; Majumder M; Tareq AM; Amin MN; Shahriar A; Uddin MZ; Dutta M; Tallei TE; Emran TB; Simal-Gandara J Molecules; 2020 Aug; 25(17):. PubMed ID: 32872217 [TBL] [Abstract][Full Text] [Related]
11. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890 [TBL] [Abstract][Full Text] [Related]
12. Current Perspective of Antiviral Strategies against COVID-19. Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102 [TBL] [Abstract][Full Text] [Related]
13. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166 [TBL] [Abstract][Full Text] [Related]
14. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406 [TBL] [Abstract][Full Text] [Related]
15. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Joshi T; Joshi T; Sharma P; Mathpal S; Pundir H; Bhatt V; Chandra S Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4529-4536. PubMed ID: 32373991 [TBL] [Abstract][Full Text] [Related]
16. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. Blaess M; Kaiser L; Sauer M; Csuk R; Deigner HP Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668803 [TBL] [Abstract][Full Text] [Related]
17. Ayurvedic and Chinese Herbs against Coronaviruses. Gasmi A; Kanwal S; Oliinyk P; Lysiuk R; Shanaida M; Gasmi Benahmed A; Dushmantha WKT; Arshad M; Kernychna I; Lenchyk L; Upyr T; Shanaida V; Bjørklund G Curr Pharm Des; 2024; 30(21):1681-1698. PubMed ID: 38685809 [TBL] [Abstract][Full Text] [Related]
18. H Yang G Am J Physiol Cell Physiol; 2020 Aug; 319(2):C244-C249. PubMed ID: 32515982 [TBL] [Abstract][Full Text] [Related]
19. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options. Asghari A; Naseri M; Safari H; Saboory E; Parsamanesh N DNA Cell Biol; 2020 Oct; 39(10):1741-1753. PubMed ID: 32716648 [TBL] [Abstract][Full Text] [Related]
20. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2. Patil AM; Göthert JR; Khairnar V Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]